Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Infection prevention product manufacturer Tristel booked an 18% rise in annual profit driven by sales growth both at home and abroad.
Pre-tax profit for the year through June rose to £4.7m, compared to a profit of £4.0m on-year.
Revenue rose 18% to £26.2m, with overseas sales up 26% to £14.4m.
Tristel declared a full-year dividend of 5.54p per share, up 21% on-year.
'We made solid progress during the year,' chief executive Paul Swinney said.
'Top-line growth was driven by our overseas operations and this trend should continue with the acquisition of four of our main European distributors during the year and shortly after the year-end.'
'We were also pleased with 9% sales growth in the United Kingdom which was higher than in recent years.'